Search
for
Sort by
Research 30 of 1000+
- Anti-Androgen Drugs in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review
- Antiandrogen Drugs Lower Serum Prostate-Specific Antigen (PSA) Levels in Hirsute Subjects: Evidence That Serum PSA Is a Marker of Androgen Action in Women<sup>1</sup>
- Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride
- Structure of human steroid 5α-reductase 2 with anti-androgen drug finasteride
- Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
- Anti-androgen hormonal therapy for cancer and other diseases
- Hirsutism – From Diagnosis to Use of Antiandrogens
- The Effect of Mesenchymal Stem Cells Derived-Conditioned Media in Combination with Oral Anti-Androgenic Drugs on Male Pattern Baldness: An Animal Study.
- Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
- Role of androgens in female-pattern androgenetic alopecia, either alone or associated with other symptoms of hyperandrogenism
- Androgen Induction of Follicular Epithelial Cell Growth Is Mediated via Insulin-like Growth Factor-I from Dermal Papilla Cells
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- COVID‐19, androgens, and androgenic alopecia
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Androgen Biosynthesis Inhibitors and Androgen Receptor Antagonists
- [Effects of androgens on the skin. Therpeutic implications].
- Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials
- Efficacy, safety and tolerability of drugs for alopecia: a comprehensive review
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Antiandrogens and Androgen Inhibitors
- Antiandrogenic drugs, a therapeutic option for frontal fibrosing alopecia patients
- Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Synthesis of 17β-N-arylcarbamoylandrost-4-en-3-one derivatives and their anti-proliferative effect on human androgen-sensitive LNCaP cell line
- Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
- Androgenetic Alopecia: An Evidence-Based Treatment Update
- Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women
- Polycystic Ovary Syndrome: Diagnosis and Treatment
- A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism
- Medical treatment regimens of hirsutism